Management

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Management
Nachum "Homi" Shamir
Chairman, President and Chief Executive Officer
Mr. Shamir joined Luminex Corporation in October, 2014. Mr. Shamir previously served, from 2006 to 2014, as President and CEO of Given Imaging, a developer, manufacturer, and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract. Prior to joining Given Imaging, Mr. Shamir was Corporate Vice President of Eastman Kodak Company and President of Eastman Kodak´s Transaction and Industrial Solutions Group. Additionally, he served over 10 years at Scitex Corporation in positions of increasing responsibility, including President and CEO from 2003 to 2004. Prior to Scitex Corporation, Mr. Shamir held senior management positions at various international companies mainly in the Asia Pacific regions. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.
Harriss T. Currie
Chief Financial Officer, Senior Vice President, Finance and Treasurer
Mr. Currie was elected as the VP, Finance, Treasurer and Chief Financial Officer in October of 2003. Since joining the company in November of 1998, Mr. Currie served in the capacities of Controller, Treasurer and Acting Chief Financial Officer. Prior to joining Luminex, he was employed as the Chief Financial Officer, Secretary and Treasurer of SpectraCell Laboratories from 1993 to 1998 where he also served as Vice President of Finance for two subsidiary companies. Mr. Currie earned his B.B.A. from Southwestern University in 1986 and his M.B.A. in Finance and Marketing from The University of Texas at Austin in 1992. Prior to returning to school for his M.B.A., Mr. Currie was a certified public accountant with Deloitte & Touche LLP.
Todd C. Bennett
Senior Vice President, Global Sales and Customer Operations
Mr. Bennett’s industry background includes over 22 years’ experience and demonstrated performance excellence in the in-vitro diagnostics and biotechnology industries. He joined Luminex in October 2012 as General Manager, Americas. Prior to Luminex, he held roles as VP of Sales and VP of Commercial Operations at Immucor, Inc., where he was responsible for Commercial Operations (Sales, Marketing, Customer Service functions). His expertise includes commercial management, business development, global marketing, strategic planning, executive sales, marketing and customer service management across multiple channels including—Molecular Diagnostics, Blood Bank, Clinical Chemistry, Immunoassay (Infectious Diseases & Endocrinology), Hematology, Point of Care, Diabetes Care and Laboratory Services at Abbott Laboratories and Roche Diagnostics. Mr. Bennett holds a B.S. in Business Administration with an emphasis in finance from the Max M. Fisher College of Business at The Ohio State University in Columbus, Ohio.
Charles J. Collins, Ph.D.
Senior Vice President, Research and Development
Dr. Collins joined Luminex Corporation in 2006 and was named Vice President of Systems Research and Development in May 2012. During his tenure Dr. Collins has held increasing leadership positions most recently as Senior Director of the Advanced Technology Group. As a recognized expert with over 35 publications in the field of engineering, Dr. Collins led the successful development of the MAGPIX instrument. Prior to joining Luminex, Dr. Collins conducted research at the University of Texas at Austin and the U.S. Army Research Laboratory. Dr. Collins earned his Ph.D. in solid state electronics from the University of Texas at Austin.
Nancy M. Fairchild, SPHR
Senior Vice President, Human Resources
Mrs. Fairchild joined Luminex in March of 2010 as the Senior Director of Human Resources and was promoted to Vice President, Human Resources in August 2012. She previously served as Chief Administrative Officer and Vice President of Human Resources and Organizational Development for the Electric Reliability Council of Texas (ERCOT). Prior to ERCOT, Mrs.Fairchild served as Vice President Human Resources for Esoterix, Inc., an international healthcare company specializing in laboratory services. Mrs. Fairchild is currently a member of the Board of Directors for Workforce Solutions, representing the biotech sector. She graduated with honors from Texas State University with a B.S. degree in Math Education and a Master’s degree in Counseling.
Randall “Randy” Myers
Senior Vice President, Global Manufacturing and Quality
Prior to joining the Company, Mr. Myers accepted an early retirement from Applied Materials in 2012 and has been consulting in supply chain and manufacturing operations since that time. Prior to his retirement, Mr. Myers held various positions at Applied Materials in manufacturing and operations from 1995-2012. In his final position with Applied Materials, Mr. Myers was Vice President with the Silicon Systems Group (SSG) Global Planning & Business Operations. Prior to joining Applied Materials, Mr. Myers worked at General Electric Aircraft Engines in Cincinnati, Ohio in various areas of procurement, supply chain and engineering from 1986-1995. Mr Myers attended Kettering University where he obtained a B.S. in Electrical Engineering.
Richard Rew
Senior Vice President, General Counsel and Corporate Secretary
Prior to joining the Company, Mr. Rew served as Senior Vice President, General Counsel and Secretary at ArthroCare Corporation from December 2008 until they were acquired by Smith & Nephew in 2014. Mr. Rew joined ArthroCare in 2006 as its Vice President, Legal Affairs. Mr. Rew previously served as General Counsel of Activant Solutions Inc. from 2000-2006 and as General Counsel of EZCORP, Inc. from 1996-2000. Mr. Rew earned a B.A. from the Plan II honors program at the University of Texas at Austin and a J.D from the University of Oklahoma College of Law. Mr. Rew is a Member of the State Bar of Texas.
Eric S. Shapiro
Senior Vice President, Global Marketing
Mr. Shapiro joined Luminex in October, 2015 as the Vice President of Global Marketing, and was promoted to Senior Vice President, Global Marketing in February, 2018. Prior to joining the company on a full-time basis, Mr. Shapiro worked with Luminex on a consulting basis as a General Manager for the Market Launch of ARIES® and NxTAG® RPP. Mr. Shapiro has previously served as a Vice President of Marketing for Given Imaging, and held numerous leadership positions at Kinetic Concepts, Inc., including Vice President of Marketing, Vice President of Patient Administration, Director of Corporate Development, and Director of Mergers and Acquisitions. Mr. Shapiro began his career working in both office and hospital-based Sales positions with Merrell Dow and Marion Merrell Dow. He currently serves on the Board of Directors for the Austin Chamber of Commerce. Mr. Shapiro holds a B.S. degree from Syracuse University, with an emphasis in Marketing and Telecommunications Management, and an M.B.A. from the J.L. Kellogg Graduate School of Management, with an emphasis in Marketing, Healthcare, Organizational Behavior, and Economics.
Steven Back
Vice President, Global Quality Assurance
Mr. Back joined Luminex Corporation as Vice President of Manufacturing in June of 2008. Prior to joining Luminex, Mr. Back was employed for 18 years at Abbott Laboratories Diagnostic Division in Dallas. While at Abbott, he held various management and technical positions in Manufacturing Operations, Technical Product Development and Quality. Prior to joining Abbott Laboratories, he was a Test Development Engineer for General Dynamics in Ft. Worth Texas. Mr. Back graduated from Wright State University in 1984 with a B.S. degree in Systems Engineering and holds an M.S.E.E degree from the University of Texas at Arlington as well as a M.B.A from the University of Dallas.
David Bourne
Vice President, Business Development and Strategic Planning
Mr. Bourne was appointed Vice President, Business Development and Strategic Planning in January, 2015. Previously, he held roles of increasing responsibility within the Business Development function, most recently as Senior Director. Mr. Bourne joined Tm Bioscience in July 2006, which became Luminex Molecular Diagnostics following the acquisition of Tm Bioscience by Luminex in March 2007. Prior to joining Tm, he worked at Merck KGaA and Bayer in a variety of business development, sales management and general management roles. Mr. Bourne earned a B.Sc. in Chemistry from McMaster University.
Travis Davies
Vice President, Instruments, Reagents, and Consumable Manufacturing

Mr. Davies was appointed Vice President, Instruments, Reagents, and Consumable Manufacturing in February, 2019 with responsibility for Luminex’s flow cytometry, microcapillary flow cytometry, imaging, and real-time PCR platforms. Mr. Davies joined Luminex in 1996 as one of the company’s earliest hires, and made foundational contributions to the proof of concept, product development, and commercialization readiness of Luminex’s xMAP® Technology. Since this time, he has held a range of Manufacturing Operations leadership roles in which he has architected teams, programs, processes, and driven continuous improvement. Mr. Davies holds a B.S. degree in Microbiology from The University of Texas at Arlington.

Tom DesRoches
Vice President, Licensed Technologies Group
Tom DesRoches joined Luminex in September of 2010 as Director of Sales, Molecular Diagnostics, Americas. He was promoted to Senior Director, Corporate Accounts and Marketing in January, 2014 and to Vice President, Licensed Technologies Group in May, 2018. Prior to Luminex from 2004 to 2010, Tom was with Roche Diagnostics, where he served as Director, Market Development, leading the Molecular Centers of Excellence program, and then as Corporate Account Director, for Roche and Ventana. Prior to Roche, he held various commercial leadership positions with Abbott Laboratories and Quest Diagnostics dating from 1994 to 2004. Mr. DesRoches holds a B.S. in Marketing Management from the Pamplin College of Business, Virginia Polytechnic Institute & State University.
 
Kendel B. Martin, CPA
Vice President, Accounting
Mrs. Martin joined Luminex Corporation in December 2007 and currently serves as Vice President, Accounting. In this capacity, Mrs. Martin has responsibility for Finance and Accounting, Financial Planning and Analysis and Facilities. Previously at Luminex Corporation, Mrs. Martin held the position of Executive Director, Finance and Accounting and Director of Financial Reporting. Prior to joining Luminex Corporation, Mrs. Martin held management roles as External Reporting Manager at Freescale Semiconductor, Internal Audit Manager at Cirrus Logic and Audit Senior Manager at Ernst & Young LLP. Mrs. Martin holds a B.A. in Economics from Rhodes College and is a Texas Certified Public Accountant.
Joern Mosner, PhD
Vice President, Research and Development
Dr. Mosner joined Luminex Corporation in February 2018 as the Vice President of Assay R&D. Prior to joining Luminex, Dr. Mosner worked at Siemens Healthineers for 13 years, most recently as the Head of R&D for the Molecular group, responsible for Assay, Engineering and Software development. Previous to this, he was part of the Molecular Business in Berkeley CA and worked in various capacities, including transferring products to manufacturing, scouting and strategy development, pre-development, and NGS activities. Dr. Mosner began his career at Siemens as a Manager in Business Development, where he was responsible for conducting technical evaluations, including lab-on-a-chip- and mass spec technologies. Prior to joining Siemens, he was the founder of a DNA sequencing biotech company where he developed a cattle and beef traceability system based on genotyping. Dr. Mosner received his PhD from the University of Hamburg, Molecular Biology department.
David B. Oldham
Vice President, Systems Research and Development
Mr. Oldham was promoted to Vice President of Systems R&D in January of 2018. Since joining Luminex in 2008, Mr. Oldham established and led the R&D Program Management Office, resulting in the successful development and launch of more than 15 IVD-cleared Luminex products and platforms. Prior to joining Luminex, Mr. Oldham held various leadership positions in product development engineering and program management at Advanced Micro Devices (AMD) from 1993 to 2008. Prior to AMD, he held engineering positions at IBM and Magma Copper Company. Mr. Oldham earned his B.S. degree in Electrical Engineering from the University of Arizona and an M.S. in Engineering Management from Walden University.
Reid Sadler
Vice President, Sales and Marketing Americas
Ryan Snellings
Vice President, Global Customer Operations

Ryan Snellings joined Luminex in August 2018 as the Vice President of Global Customer Operations. Ryan supports both operations and sales functions across the globe to ensure a positive customer experience. Prior to Luminex, Ryan was responsible for Fenwal, Inc.’s Europe, Middle East, and Africa operations before Fenwal, Inc. was acquired by Fresenius Kabi in 2013. With the acquisition, Ryan was promoted to Vice President of Field Service and Support at Fresenius Kabi. Over the last few years, Ryan has held international leadership roles with increasing responsibility for both North America and Europe. Ryan is a graduate from Florida State University with an MBA from Keller Graduate School of Management.

 

Board of Directors
Nachum “Homi” Shamir
Chairman, President and Chief Executive Officer, Executive Committee, Strategy & Development Committee
Mr. Shamir joined the Company in October 2014 as President and Chief Executive Officer and was elected to our Board. From 2006 to 2014, Mr. Shamir was the President, Chief Executive Officer and Director of Given Imaging Ltd., a developer of the PillCam capsule, and manufacturer and marketer of diagnostic products for the visualization and detection of disorders of the gastrointestinal tract, which was acquired by Covidien PLC in early 2014. Mr. Shamir currently serves on the board of directors of Invendo Medical GmbH, a manufacturer and distributor of a single use and computer-assisted colonoscopy system. Mr. Shamir holds a Bachelor of Science from the Hebrew University of Jerusalem and a Masters of Public Administration from Harvard University.
Stephen L. Eck M.D., Ph.D
Chairmain of the Strategy & Development Committee, Nominating and Corporate Governance Committee, Compensation Committee

Stephen L. Eck, MD, PhD, age 61, joined the board of directors in March 2016. Since 2011 he has served as the Vice President, Oncology Medical Sciences of Astellas Pharma Global Development, a global pharmaceutical company. He is responsible for the design and conduct of domestic and international oncology clinical studies, which include the use of molecular testing for disease diagnosis and to monitor drug efficacy and safety.

From 2007 to 2011, Dr. Eck served as Vice President, Translational Medicine & Pharmacogenomics at Eli Lilly, a global pharmaceutical company. There, he was responsible for the clinical pharmacology components of drug development, including both early phase clinical studies and late stage drug development studies. He was responsible for the Diagnostic and Experimental Medicines and laboratory for Experimental Medicine departments which designed, built and deployed novel clinical test platforms to be used in clinical studies. Before his tenure at Eli Lily, Dr. Eck led drug development teams at Pfizer from 2002 to 2007, including the Molecular Profiling Group and the Translational Medicine organization.

Prior to joining the pharmaceutic industry, Dr. Eck was a member of the faculty of the University of Pennsylvania School of Medicine, where he focused on Hematology and Oncology. He is a Fellow of the American Association for the Advancement of Science. He also serves on the Scientific Advisory Board of the ACGT Foundation, the Board of Trustees of the Keck Graduate Institute, the Board of Directors of the Central Pennsylvania Clinic, and on the Board of Directors of the Personalized Medicine Coalition. Dr. Eck holds a B.S. in Chemistry from Kalamazoo College, a Ph.D. in Chemistry from Harvard University and a M.D. in Medicine from the University of Mississippi.

Independent Director
Thomas W. Erickson
Chairman of the Executive Committee

Thomas W. Erickson, age 61. Mr. Erickson has served as a member of the board of directors since May 2004. Mr. Erickson served as our Interim President and Chief Executive Officer from September 2002 until our hiring of Mr. Balthrop in May 2004. He is currently chairman of the board of Inmar, Inc., a reverse logistics and revenue recovery company. Previously, he served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm, chairman and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of PATHCare, Inc., an operator of long term care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim president and chief executive officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals, and interim president and chief executive officer and director of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, he held several management positions at American Hospital Supply Corporation. Mr. Erickson currently serves on the board of directors of American Renal Associates, a national provider of kidney dialysis services. Mr. Erickson holds a Bachelors degree from University of Iowa and an M.B.A. from Southern Methodist University.

Mr. Erickson brings to the board of directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving in leadership roles on boards and board committees of other public companies. Through his experience serving as Luminex’s Interim President and Chief Executive Officer from September 2002 until May 2004, Mr. Erickson offers to the board detailed insight into the Company’s business and management considerations. Through his substantial experience in the healthcare industry, in particular healthcare services and delivery, Mr. Erickson offers valuable insight on Luminex and its product offerings from the perspective of healthcare providers.

Independent Director
Jim D. Kever
Chairman of the Compensation Committee

Jim D. Kever, age 59. Mr. Kever has served as a member of the board of directors since December 1996. He has been a member in Voyent since August 2001. Mr. Kever served as co-chief executive officer of the transaction services division of WebMD from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles. From August 1995 through March 1999, Mr. Kever was the president and co-chief executive officer of Envoy. Mr. Kever serves on the boards of directors of 3D Systems Corporation (“3D Systems”), a provider of 3-D printing, rapid prototyping and manufacturing solutions, and Tyson Foods, Inc., a food production company (“Tyson”). Within the past five years, Mr. Kever has served on the board of directors of ACI Worldwide, Inc., a global provider of electronic payments solutions for financial institutions. Mr. Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.

Mr. Kever brings to the board of directors extensive experience managing and growing healthcare industry companies. Mr. Kever brings experience in serving on public and private boards. Mr. Kever, through his more recent investment experiences with Voyent, also brings depth of knowledge in managing and growing companies and in capital market considerations. Mr. Kever also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Independent Director
Kevin M. McNamara
Chairman of the Audit Committee

Kevin M. McNamara, age 56. Mr. McNamara has served as a member of the board of directors since May 2003. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara also served as non-executive chairman from April 2005 through January 2006 of MedAvant Healthcare Solutions (f/k/a ProxyMed, Inc.), a provider of automated healthcare business and cost containment solutions for financial, administrative and clinical transactions in the healthcare payments marketplace, and served as interim chief executive officer and as a director of ProxyMed, Inc. from December 2004 through June 2005. Mr. McNamara previously served as chief financial officer of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson Foods, Inc., a food production company. Within the past five years, Mr. McNamara has served on the board of directors of COMSYS IT Partners, Inc. (f/k/a Personnel Group of America, Inc.), an information technology staffing and solutions provider. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and an M.B.A. from the University of Richmond.

Mr. McNamara brings to the board of directors extensive financial expertise, experience managing and growing healthcare industry companies, as well as significant general experience serving on boards and board committees of other public companies. Mr. McNamara’s experience overseeing risk assessment, accounting and financial reporting for public and other healthcare companies provides equally valuable experience in his role as chair of our Audit Committee. Mr. McNamara also has experience overseeing public and private capital markets and mergers and acquisitions transactions.

Financial Expert
Independent Director
Edward A. Ogunro, Ph.D.
Lead Independent Director, Strategy & Development Committee, Audit Committee, Executive Committee

Edward A. Ogunro, Ph.D., age 59. Dr. Ogunro has served as a member of our board of directors since May 2009. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott’s spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott’s Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott’s Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym, one of the most successful analyzers in the diagnostic industry, and divisional vice president for Abbott’s Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro served on the board of directors of Applied NeuroSolutions, Inc., a company focused on the development of an integrated portfolio of products for the treatment and diagnosis of Alzheimer’s disease. Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.

Dr. Ogunro brings to the board of directors significant directly relevant technical and operational industry experience in the diagnostics and medical device industry. Dr. Ogunro has substantial experience in managing complex research and development initiatives for large, evolving portfolios of diagnostic and medical device products, and in securing and maintaining regulatory clearance for such products both domestically and internationally. Dr. Ogunro’s technical background and direct experience with project management is of particular relevance in his role on the Strategy and Development Committee and in guiding Luminex in its research and development investments on new products and markets.

Independent Director
Kenneth A. Samet
Audit Committee, Nominating and Corporate Governance Committee

Mr. Samet joined our Board in December, 2018. Mr. Samet has served as Chief Executive Officer of MedStar Health, Inc., a non-profit healthcare delivery system, since 2008. He previously served as that organization’s President from 2003 and as Chief Operating Officer from 1998. From 1990 to 2000, Mr. Samet served as President of MedStar Washington Hospital Center. From the mid-1980s to 1990, he held a variety of leadership positions with the Medlantic Healthcare Group. Mr. Samet has also served as a director of Catalyst Health Solutions, Inc., Cogentix Medical, Inc., and Evolent Health, Inc. Mr. Samet received a bachelor’s degree in business administration from Old Dominion University and a master’s degree in health services administration from the University of Michigan.

Mr. Samet brings to the Board of Directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving in leadership roles on boards and board committees of other public companies. He also brings financial expertise, a diverse set of capabilities in leading the operational aspects of a large and complex organization, and experience managing issues representative of those faced by the Company’s customers.

Shareholder Tools